These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6395519)

  • 21. Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the detection of antibodies to influenza A virus in domestic and wild avian and mammalian species.
    Sullivan HJ; Blitvich BJ; VanDalen K; Bentler KT; Franklin AB; Root JJ
    J Virol Methods; 2009 Oct; 161(1):141-6. PubMed ID: 19523985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of hemagglutination-inhibition titers to influenza A virus in porcine sera by use of an enzyme-linked immunosorbent assay.
    Lee BW; Bey RF; Baarsch MJ; Morrison RB; Freese W
    Am J Vet Res; 1993 Aug; 54(8):1270-6. PubMed ID: 8214894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera.
    Shafer AL; Katz JB; Eernisse KA
    Avian Dis; 1998; 42(1):28-34. PubMed ID: 9533078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.
    Ko YJ; Choi KS; Nah JJ; Paton DJ; Oem JK; Wilsden G; Kang SY; Jo NI; Lee JH; Kim JH; Lee HW; Park JM
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):922-9. PubMed ID: 16085909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ELISA in the rapid diagnosis of influenza using as the detecting antibodies polyclonal antinucleoprotein sera].
    Lupulescu E; Ioniţă E; Constantinescu C; Tecu C; Chiriţă C; Alexandrescu V
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(1-2):63-7. PubMed ID: 8963120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The purification and application of Epstein-Barr virus gp125].
    Wang G; Pi G; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an enzyme-linked immunosorbent assay for detecting infectious bursal disease virus (IBDV) infection based on the VP3 structural protein.
    Wang MY; Hu HL; Suen SY; Chiu FY; Shien JH; Lai SY
    Vet Microbiol; 2008 Oct; 131(3-4):229-36. PubMed ID: 18485623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An enzyme-linked immunosorbent assay for the detection of hepatitis non-A, non-B antigen and antibody.
    Duermeyer W; Stute R; Hellings JA
    Dev Biol Stand; 1983; 54():475-82. PubMed ID: 6418592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rapid identification of human influenza neuraminidase N1 and N2 subtypes by ELISA.
    Barr IG; McCaig M; Durrant C; Shaw R
    Vaccine; 2006 Nov; 24(44-46):6675-8. PubMed ID: 16860447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells.
    Yarchoan R; Murphy BR; Strober W; Schneider HS; Nelson DL
    J Immunol; 1981 Dec; 127(6):2588-94. PubMed ID: 6975330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of a dengue anti-complex monoclonal antibody in viral purification].
    Hermida Díaz C; Pupo M; Guzmán Tirado MG; González Garriga M; Marcet Sánchez R
    Rev Cubana Med Trop; 1992; 44(3):171-6. PubMed ID: 9768210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple method for the purification of 5-aminosalicylic acid. Application of the product as substrate in enzyme-linked immunosorbent assay (ELISA).
    Ellens DJ; Gielkens AL
    J Immunol Methods; 1980; 37(3-4):325-32. PubMed ID: 6256447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of physico-chemical factors on the sensitivity and specificity of immunoenzyme analysis].
    Gorbachev EN; Verbov VN; Artiukhov AI
    Tr Inst Im Pastera; 1988; 64():76-80. PubMed ID: 2855895
    [No Abstract]   [Full Text] [Related]  

  • 36. Demonstration of viral antigen in cryostat sections by a new immunoperoxidase procedure eliminating endogenous peroxidase activity.
    Fink B; Loepfe E; Wyler R
    J Histochem Cytochem; 1979 Sep; 27(9):1299-301. PubMed ID: 383832
    [No Abstract]   [Full Text] [Related]  

  • 37. Virus harvesting and affinity-based liquid chromatography. A method for virus concentration and purification.
    O'Neil PF; Balkovic ES
    Biotechnology (N Y); 1993 Feb; 11(2):173-8. PubMed ID: 7763369
    [No Abstract]   [Full Text] [Related]  

  • 38. [Absorption-elution method for the purification and concentration of influenza virus antigen for ELISA].
    Rosmus K; Glanz H; Borkhardt HL
    Z Gesamte Hyg; 1984 Nov; 30(11):654-6. PubMed ID: 6395519
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid purification of avian influenza virus for use in enzyme-linked immunosorbent assay.
    Abraham A; Sivanandan V; Newman JA; Maheswaran SK
    Am J Vet Res; 1984 May; 45(5):959-62. PubMed ID: 6375486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Direct detection of influenza virus A in animal study material with the enzyme-linked immunosorbent assay (ELISA)].
    Thess G; Budde E; Helbig JH; Muschner K; Witzleb W
    Z Med Lab Diagn; 1985; 26(1):39-43. PubMed ID: 3885602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.